Here are the latest quarterly results of LAURUS LABS . For more details, see the LAURUS LABS financial fact sheet and LAURUS LABS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 14,248 | 15,389 | 15,759 | 15,448 | 13,809 | 11,818 | 12,245 | 11,949 | |
Other income | Rs m | 13 | 18 | 11 | 14 | 17 | 36 | 18 | 24 | |
Turnover | Rs m | 14,261 | 15,407 | 15,770 | 15,463 | 13,826 | 11,854 | 12,262 | 11,974 | |
Expenses | Rs m | 10,281 | 10,848 | 11,270 | 11,413 | 10,954 | 10,151 | 10,366 | 10,135 | |
Gross profit | Rs m | 3,967 | 4,542 | 4,489 | 4,036 | 2,855 | 1,667 | 1,879 | 1,814 | |
Depreciation | Rs m | 657 | 708 | 818 | 844 | 870 | 906 | 934 | 984 | |
Interest | Rs m | 306 | 293 | 401 | 427 | 531 | 392 | 424 | 508 | |
Profit before tax | Rs m | 3,017 | 3,559 | 3,281 | 2,779 | 1,471 | 406 | 539 | 346 | |
Tax | Rs m | 698 | 1,033 | 943 | 748 | 399 | 122 | 146 | 95 | |
Profit after tax | Rs m | 2,319 | 2,525 | 2,338 | 2,031 | 1,072 | 284 | 393 | 252 | |
Gross profit margin | % | 27.8 | 29.5 | 28.5 | 26.1 | 20.7 | 14.1 | 15.3 | 15.2 | |
Effective tax rate | % | 23.1 | 29.0 | 28.7 | 26.9 | 27.1 | 30.0 | 27.0 | 27.3 | |
Net profit margin | % | 16.3 | 16.4 | 14.8 | 13.1 | 7.8 | 2.4 | 3.2 | 2.1 | |
Diluted EPS | Rs | 4.3 | 4.7 | 4.3 | 3.8 | 2.0 | 0.5 | 0.7 | 0.5 | |
Diluted EPS (TTM) | Rs | 15.4 | 15.6 | 16.2 | 17.1 | 14.8 | 10.6 | 7.0 | 3.7 | |
Subscriber Feature |
Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.